The filing

Intimation of acquisition of a step down subsidiary in USA.

Company

Aurobindo Pharma Ltd · BSE 524804

Filed

2 October 2026, 18:09 IST

BSE category

Company Update / Acquisition

Tag

Acquisition · selected

Source

Open the filing on BSE →

Why it led

• Mid cap · NIFTY 500

Selected by the ranker from 15 filings that day. Each line above is a component of that score, not a comment on the filing.

How often this tag appears

505 of 90,553 filings in the published window carry Acquisition · 0.56%

Around it

Also filed by Aurobindo Pharma Ltd on 2 October 2026

• Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. General18:35 IST

Most recent filings from Aurobindo Pharma Ltd

• Newspaper Publication Newspaper Publication9 October 2026 · 11:33 IST
• Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 Compliance Certificate5 October 2026 · 13:11 IST
• Disclosure Under Regulation 30 Of The SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015. General2 October 2026 · 18:35 IST